Walgreens Boots Alliance Inc. logo

Walgreens Boots Alliance Inc. (WBA)

Delisted
28 Aug 2025
NASDAQ (NGS) NASDAQ (NGS)
$
11. 98
+0.06
+0.5034%
$
10.37B Market Cap
- P/E Ratio
1% Div Yield
452.08M Volume
3.23 Eps
$ 11.92
Previous Close
Investors:
Day Range
11.98 11.98
Year Range
8.08 13.25
Want to track WBA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
The latest step in Walgreens' turnaround is a blow to investors

The latest step in Walgreens' turnaround is a blow to investors

Walgreens has struggled as foot traffic at its stores dwindle and pharmacy business faces slimmer reimbursement rates on prescription drugs.

Marketwatch | 1 year ago
Walgreens Suspends Quarterly Dividend Amid Turnaround Efforts

Walgreens Suspends Quarterly Dividend Amid Turnaround Efforts

Walgreens Boots Alliance is suspending its quarterly dividend as the company works to “evaluate and refine its capital allocation policy consistent with the company's broader long-term turnaround efforts.”

Forbes | 1 year ago
Walgreens suspends quarterly dividend amid turnaround efforts

Walgreens suspends quarterly dividend amid turnaround efforts

Walgreens Boots Alliance has suspended its quarterly cash dividend amid restructuring efforts, the U.S. pharmacy chain operator said on Thursday, sending its shares down nearly 8% in extended trading.

Reuters | 1 year ago
Why Walgreens Boots Alliance Stock Sank by Almost 5% Today

Why Walgreens Boots Alliance Stock Sank by Almost 5% Today

No investor likes it when a potential buyout deal for one of their holdings hits a serious roadblock. This is apparently happening to Walgreens Boots Alliance (WBA -4.46%), according to a media report.

Fool | 1 year ago
Walgreens Stock Tumbles. Report Says Private-Equity Bid for Pharmacy Chain ‘Mostly Dead.

Walgreens Stock Tumbles. Report Says Private-Equity Bid for Pharmacy Chain ‘Mostly Dead.

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.

Barrons | 1 year ago
Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound

Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound

After a tough year for Walgreens (WBA) investors in 2024, shares may have appeared poised to start 2025 on strong note after the company's first-quarter results topped expectations.

Investopedia | 1 year ago
S&P 500 Gains and Losses Today: Walgreens Stock Plummets as DOJ Files Lawsuit

S&P 500 Gains and Losses Today: Walgreens Stock Plummets as DOJ Files Lawsuit

Major U.S. equities indexes advanced as the markets kicked off a shortened trading week following the Martin Luther King Jr. holiday and President Donald Trump's inauguration.

Investopedia | 1 year ago
Walgreens Stock Tumbles on DOJ Lawsuit Over 'Millions' of Alleged Illegal Prescriptions

Walgreens Stock Tumbles on DOJ Lawsuit Over 'Millions' of Alleged Illegal Prescriptions

Walgreens Boots Alliance (WBA) shares sank Tuesday, the first day of trading since the Department of Justice (DOJ) on Friday announced a lawsuit accusing the pharmacy chain of dispensing "millions of unlawful prescriptions" that had no legitimate medical purpose.

Investopedia | 1 year ago
Why Walgreens Boots Alliance Stock Was Sliding Today

Why Walgreens Boots Alliance Stock Was Sliding Today

Shares of Walgreens Boots Alliance (WBA -12.50%) pulled back today after the company again ran into trouble with regulators.

Fool | 1 year ago
Justice Department Accuses Walgreens Of Violating Drug Laws In Opioid Epidemic, Ignored Red Flags In Opioid Crisis

Justice Department Accuses Walgreens Of Violating Drug Laws In Opioid Epidemic, Ignored Red Flags In Opioid Crisis

Last week, the U.S. Department of Justice filed a civil complaint against Walgreens Boots Alliance Inc WBA and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) and False Claims Act (FCA).

Benzinga | 1 year ago
Walgreens Reverses 40% Sprint As DOJ Slams Opioid Prescriptions

Walgreens Reverses 40% Sprint As DOJ Slams Opioid Prescriptions

Walgreens stock tumbled Tuesday after the DOJ said the retail pharmacy violated federal law by filling controlled substance prescriptions. The post Walgreens Reverses 40% Sprint As DOJ Slams Opioid Prescriptions appeared first on Investor's Business Daily.

Investors | 1 year ago
Walgreens set for hammering after unlawful opioid allegations

Walgreens set for hammering after unlawful opioid allegations

Walgreens Boots Alliance Inc is set for a hammering when the market reopens on Tuesday after being accused by the government of filling unlawful opioid prescriptions.   America's US Justice Department late last week alleged the pharmacy chain had contributed to the opioid epidemic by filling millions of unlawful prescriptions.

Proactiveinvestors | 1 year ago
Loading...
Load More